Abstract
Gastric cancer is a common and highly lethal malignancy of the digestive system, with surgical resection as the primary treatment approach. However, postoperative analgesia management remains a major clinical challenge. Postoperative pain not only affects recovery speed but may also lead to complications, thereby influencing prognosis. Recent research on postoperative pain following gastric cancer surgery has expanded, exploring various analgesic methods, including pharmacological therapy, neuraxial blocks, and non-pharmacological approaches, with growing emphasis on individualized analgesia protocols. This review discusses the physiological mechanisms of postoperative pain following gastric cancer surgery, modern analgesic strategies, and related research to provide a theoretical basis and clinical guidance for improving postoperative quality of life.
Introduction: The Challenge of Postoperative Pain
Radical gastrectomy involves extensive tissue resection and reconstruction, resulting in significant surgical trauma. Beyond patient discomfort, acute postoperative pain triggers a cascade of inflammatory responses, delays mobilization, and increases the risk of pulmonary and cardiovascular complications.
Crucially, persistent inflammatory stimulation can cause structural changes in neurons, creating a "memory" of pain known as central sensitization. This process can transition acute surgical pain into a debilitating chronic condition, making aggressive early intervention essential. While opioids have traditionally been the cornerstone of pain management, their side effects—including nausea, vomiting, respiratory depression, and potential for addiction—often impede the recovery process. Modern clinical practice is therefore shifting toward multimodal analgesia, a "cocktail" approach that combines different techniques to provide superior relief with minimal adverse effects.
Regional and Central Analgesic Techniques
One of the most significant advancements in postoperative care is the "nerve block revolution." Ultrasound-guided peripheral nerve blocks allow for targeted pain relief, significantly reducing the systemic requirement for opioids.
Techniques such as the Transversus Abdominis Plane Block (TAPB) and Erector Spinae Plane Block (ESPB) have shown remarkable efficacy. Studies indicate these blocks can reduce Visual Analog Scale (VAS) pain scores by 40%–50% at 48 hours post-surgery. Other methods, like the Paravertebral Block (PVB), simultaneously inhibit somatic and visceral pain, offering a comprehensive analgesic profile for upper abdominal surgeries.
Systemic Pharmacological Strategies
Systemic analgesia remains a foundational component of multimodal protocols, typically delivered via Patient-Controlled Intravenous Analgesia (PCIA). However, the choice of drug is critical for balancing efficacy and safety. For instance, Oxycodone is frequently preferred for visceral pain due to its high lipophilicity and superior efficacy in managing internal organ discomfort compared to other opioids.
The review highlights that while Patient-Controlled Epidural Analgesia (PCEA) often provides better pain relief and shorter hospital stays than PCIA, it requires more intensive monitoring for side effects like hypotension. To optimize outcomes, clinicians often combine opioids with non-steroidal anti-inflammatory drugs (NSAIDs) or adjuvants like Dexmedetomidine and Ketamine, which help inhibit central sensitization and reduce overall narcotic consumption.
Holistic and Non-Pharmacological Adjuvants
Pain perception is not purely physiological; it is deeply intertwined with a patient's psychological state. Anxiety and depression can physically amplify pain through shared neurological pathways. Integrating psychological support, such as Cognitive Behavioral Therapy (CBT), is increasingly recognized as a clinical necessity rather than an optional extra.
Furthermore, alternative therapies like acupuncture and Transcutaneous Electrical Nerve Stimulation (TEAS) have demonstrated success in not only reducing pain scores but also accelerating the recovery of postoperative digestive function, fitting perfectly within "Enhanced Recovery After Surgery" (ERAS) frameworks.
Conclusion and Future Directions
The current gold standard for post-gastrectomy pain is a four-step multimodal protocol: prioritizing regional anesthesia, establishing a foundation of non-opioids, using rescue opioids only when necessary, and performing dynamic reassessments every 72 hours.
Looking forward, the field is moving toward "Precision Analgesia." By leveraging biomarkers and genomics, clinicians may soon be able to predict individual responses to specific analgesics. Additionally, the integration of Artificial Intelligence in drug discovery and multidisciplinary collaboration models promises to treat pain as a holistic metric of surgical recovery, ultimately improving the long-term prognosis for gastric cancer patients.
Summary updated